Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of type 2 diabetes. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://lexieefvz533076.like-blogs.com/38799315/retaglutide-a-promising-glp-1-receptor-agonist